Shanghai Life Science & Technology Report issue

For profit Phase 1
Founded: Shanghai China (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2019
NCT03902067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shanghai Life Science & Technology